A renin-angiotenzin rendszer gátlása a célszervkárosodások megelózésében: a "renalis continuum".

Translated title of the contribution: Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"

Research output: Contribution to journalArticle

Abstract

Similar to the atherosclerotic cardiovascular disease, primary and secondary renal diseases are also characterised by a "continuum". The "renal continuum" comprises the initial immunologic, metabolic or hemodynamic insult which, through progressive glomerular and interstitial renal damage, results in end stage renal failure. The rennin-angiotensin system plays a pivotal role in the progression of renal disease. We use diabetic nephropathy to demonstrate the clinical benefits that can be attained by administering inhibitors of the rennin-angiotensin system in more and more progressive stages of the diabetic "renal continuum". Evidence from clinical trials among diabetic patients attest to the notion that specific inhibition of the rennin-angiotensin system provides a benefit that is above what could be expected from the blood pressure lowering effects of these drugs alone.

Original languageHungarian
Pages (from-to)898-901
Number of pages4
JournalOrvosi Hetilap
Volume144
Issue number18 Suppl 1
Publication statusPublished - May 4 2003

Fingerprint

Renin-Angiotensin System
Chymosin
Kidney
Angiotensins
Diabetic Nephropathies
Chronic Kidney Failure
Disease Progression
Cardiovascular Diseases
Hemodynamics
Clinical Trials
Blood Pressure
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A renin-angiotenzin rendszer gátlása a célszervkárosodások megelózésében : a "renalis continuum". / Tislér, A.

In: Orvosi Hetilap, Vol. 144, No. 18 Suppl 1, 04.05.2003, p. 898-901.

Research output: Contribution to journalArticle

@article{6236d6eb0d204c7bab84b4cd2459ac27,
title = "A renin-angiotenzin rendszer g{\'a}tl{\'a}sa a c{\'e}lszervk{\'a}rosod{\'a}sok megel{\'o}z{\'e}s{\'e}ben: a {"}renalis continuum{"}.",
abstract = "Similar to the atherosclerotic cardiovascular disease, primary and secondary renal diseases are also characterised by a {"}continuum{"}. The {"}renal continuum{"} comprises the initial immunologic, metabolic or hemodynamic insult which, through progressive glomerular and interstitial renal damage, results in end stage renal failure. The rennin-angiotensin system plays a pivotal role in the progression of renal disease. We use diabetic nephropathy to demonstrate the clinical benefits that can be attained by administering inhibitors of the rennin-angiotensin system in more and more progressive stages of the diabetic {"}renal continuum{"}. Evidence from clinical trials among diabetic patients attest to the notion that specific inhibition of the rennin-angiotensin system provides a benefit that is above what could be expected from the blood pressure lowering effects of these drugs alone.",
author = "A. Tisl{\'e}r",
year = "2003",
month = "5",
day = "4",
language = "Hungarian",
volume = "144",
pages = "898--901",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "18 Suppl 1",

}

TY - JOUR

T1 - A renin-angiotenzin rendszer gátlása a célszervkárosodások megelózésében

T2 - a "renalis continuum".

AU - Tislér, A.

PY - 2003/5/4

Y1 - 2003/5/4

N2 - Similar to the atherosclerotic cardiovascular disease, primary and secondary renal diseases are also characterised by a "continuum". The "renal continuum" comprises the initial immunologic, metabolic or hemodynamic insult which, through progressive glomerular and interstitial renal damage, results in end stage renal failure. The rennin-angiotensin system plays a pivotal role in the progression of renal disease. We use diabetic nephropathy to demonstrate the clinical benefits that can be attained by administering inhibitors of the rennin-angiotensin system in more and more progressive stages of the diabetic "renal continuum". Evidence from clinical trials among diabetic patients attest to the notion that specific inhibition of the rennin-angiotensin system provides a benefit that is above what could be expected from the blood pressure lowering effects of these drugs alone.

AB - Similar to the atherosclerotic cardiovascular disease, primary and secondary renal diseases are also characterised by a "continuum". The "renal continuum" comprises the initial immunologic, metabolic or hemodynamic insult which, through progressive glomerular and interstitial renal damage, results in end stage renal failure. The rennin-angiotensin system plays a pivotal role in the progression of renal disease. We use diabetic nephropathy to demonstrate the clinical benefits that can be attained by administering inhibitors of the rennin-angiotensin system in more and more progressive stages of the diabetic "renal continuum". Evidence from clinical trials among diabetic patients attest to the notion that specific inhibition of the rennin-angiotensin system provides a benefit that is above what could be expected from the blood pressure lowering effects of these drugs alone.

UR - http://www.scopus.com/inward/record.url?scp=0037805688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037805688&partnerID=8YFLogxK

M3 - Article

C2 - 12785234

AN - SCOPUS:0037805688

VL - 144

SP - 898

EP - 901

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 18 Suppl 1

ER -